Cryoport launches new solution for regenerative therapy systems

摘要

Cryoport Inc., the cryogenic logistics company dedicated to the life sciences industry, has launched its 'Cryoport. Certified. Cool.' solution designed to provide cold-chain logistics in the 2-8°C temperature range for regenerative therapy requirements. The solution, which will be branded as C3, is designed for synergistic integration into its intuitive informatics platform, the Cryoportal Logistics Management Platform. The shipper provides enhanced, real-time visibility, security and risk mitigation from temperature excursions for the clients critical biological commodities. The introduction of C3 means that Cryoport can support the entire logistics continuum for regenerative medicine clinical and commercial programs.